FDA Watch: EU’s New IVD Regulations Could Drive More Firms to Seek FDA Approval
Although the timelines have been extended several times, IVDR complexity has created a concerning bottleneck in the approval process
FDA-lca
Subscribe today for access to
Articles and Reports
Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
FDA Details Oversight of Medical Applications On Smart Phones and Tablets
...
Already a member? Log in here
Final FDA Guidance on RUO, IUO Products Raises Compliance Concerns for Labs
...
Already a member? Log in here
- « Previous
- 1
- …
- 3
- 4
- 5